Martine A. Rothblatt - 15 Dec 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
15 Dec 2022
Net transactions value
-$1,298,253
Form type
4
Filing time
19 Dec 2022, 16:13:43 UTC
Previous filing
15 Dec 2022
Next filing
20 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $904,640 +8,000 +6154% $113.08 8,130 15 Dec 2022 Direct F1
transaction UTHR Common Stock Sale $162,457 -598 -7.4% $271.67 7,532 15 Dec 2022 Direct F1, F2
transaction UTHR Common Stock Sale $332,534 -1,219 -16% $272.79 6,313 15 Dec 2022 Direct F1, F3
transaction UTHR Common Stock Sale $67,313 -246 -3.9% $273.63 6,067 15 Dec 2022 Direct F1, F4
transaction UTHR Common Stock Sale $195,784 -711 -12% $275.36 5,356 15 Dec 2022 Direct F1, F5
transaction UTHR Common Stock Sale $936,631 -3,392 -63% $276.13 1,964 15 Dec 2022 Direct F1, F6
transaction UTHR Common Stock Sale $508,174 -1,834 -93% $277.08 130 15 Dec 2022 Direct F1, F7
holding UTHR Common Stock 166 15 Dec 2022 By Spouse
holding UTHR Common Stock 651,549 15 Dec 2022 By Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -8,000 -1% $0.000000 760,000 15 Dec 2022 Common Stock 8,000 $113.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $271.125 to $272.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $272.245 to $273.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $273.29 to $274.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $274.585 to $275.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $275.605 to $276.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $276.635 to $277.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.